Lymphoma
Lymphoma is a malignant tumor originating from lymph nodes or lymphatic tissues. The main clinical manifestation is painless, progressive lymphadenopathy. The disease can occur at any age, but the peak age of onset is between 31 and 40 years old, with the peak of non-Hodgkin's lymphoma slightly earlier. The male-to-female ratio is 2-3:1.
-
Site of disease:
lymph -
Infectious :
Not contagious -
Frequent population:
Young Adults -
Related symptoms:
Lymph node enlargement hepatosplenomegaly weight loss night sweats persistent fever
Related Drugs
Methotrexate
Indication: 1. Systemic medication for the treatment of choriocarcinoma, malignant hydatidiform mole, various acute leukemias with breast cancer, lung cancer, head and neck cancer, digestive tract cancer, cervical cancer and malignant lymphoma. 2. Arterial catheter perfusion has a good effect on head and neck cancer and liver cancer. 3. High-dose methotrexate supplemented with calcium folinate rescue (HDMTX-CFR therapy) has a certain effect as postoperative adjuvant chemotherapy or systemic treatment of advanced lesions for osteosarcoma, soft tissue sarcoma, malignant lymphoma, acute lymphocytic leukemia with breast cancer, ovarian cancer, small cell lung cancer, etc.
Methotrexate
Indication: 1. Systemic medication for the treatment of choriocarcinoma, malignant hydatidiform mole, various acute leukemias with breast cancer, lung cancer, head and neck cancer, digestive tract cancer, cervical cancer and malignant lymphoma. 2. Arterial catheter perfusion has a good effect on head and neck cancer and liver cancer. 3. High-dose methotrexate supplemented with calcium folinate rescue (HDMTX-CFR therapy) has a certain effect as postoperative adjuvant chemotherapy or systemic treatment of advanced lesions for osteosarcoma, soft tissue sarcoma, malignant lymphoma, acute lymphocytic leukemia with breast cancer, ovarian cancer, small cell lung cancer, etc.
Manufacturer:
Bei Jing Scrianen Pharmaceutical Co., Ltd.
Methotrexate
Indication: 1. Systemic medication for the treatment of choriocarcinoma, malignant hydatidiform mole, various acute leukemias with breast cancer, lung cancer, head and neck cancer, digestive tract cancer, cervical cancer and malignant lymphoma. 2. Arterial catheter perfusion has a good effect on head and neck cancer and liver cancer. 3. High-dose methotrexate supplemented with calcium folinate rescue (HDMTX-CFR therapy) has a certain effect as postoperative adjuvant chemotherapy or systemic treatment of advanced lesions for osteosarcoma, soft tissue sarcoma, malignant lymphoma, acute lymphocytic leukemia with breast cancer, ovarian cancer, small cell lung cancer, etc.
Manufacturer:
Zhejiang Hisun Pharmaceutical Co., Ltd.
Methotrexate
Indication: 1. Systemic medication for the treatment of choriocarcinoma, malignant hydatidiform mole, various acute leukemias with breast cancer, lung cancer, head and neck cancer, digestive tract cancer, cervical cancer and malignant lymphoma. 2. Arterial catheter perfusion has a good effect on head and neck cancer and liver cancer. 3. High-dose methotrexate supplemented with calcium folinate rescue (HDMTX-CFR therapy) has a certain effect as postoperative adjuvant chemotherapy or systemic treatment of advanced lesions for osteosarcoma, soft tissue sarcoma, malignant lymphoma, acute lymphocytic leukemia with breast cancer, ovarian cancer, small cell lung cancer, etc.
Manufacturer:
Huzhou Zhanwang Pharmaceutical Co., Ltd.
Methotrexate tablets
Indication: 1. All types of acute leukemia, especially acute lymphocytic leukemia, malignant lymphoma, non-Hodgkin's lymphoma, mycosis fungoides, and multiple myelopathy; 2. Head and neck cancer, lung cancer, various soft tissue sarcomas, and psoriasis; 3. Breast cancer, ovarian cancer, cervical cancer, malignant hydatidiform mole, choriocarcinoma, and testicular cancer.
Manufacturer:
Hunan Zhengqing Pharmaceutical Co., Ltd.
Ifosfamide
Indication: 1. This product has a wide anti-tumor spectrum and is mainly suitable for soft tissue tumors, testicular tumors, malignant lymphomas, lung cancer, breast cancer, ovarian cancer, cervical cancer and childhood tumors; 2. Used for anti-tumor: leukemia, spermatogonial testicular cancer, lung cancer, non-Hodgkin's lymphoma, cervical cancer, ovarian cancer and recurrent and refractory solid tumors.
Ifosfamide
Indication: 1. This product has a wide anti-tumor spectrum and is mainly suitable for soft tissue tumors, testicular tumors, malignant lymphomas, lung cancer, breast cancer, ovarian cancer, cervical cancer and childhood tumors; 2. Used for anti-tumor: leukemia, spermatogonial testicular cancer, lung cancer, non-Hodgkin's lymphoma, cervical cancer, ovarian cancer and recurrent and refractory solid tumors.
Manufacturer:
Shandong Ruiying Pioneer Pharmaceutical Co., Ltd.
Ifosfamide
Indication: 1. This product has a wide anti-tumor spectrum and is mainly suitable for soft tissue tumors, testicular tumors, malignant lymphomas, lung cancer, breast cancer, ovarian cancer, cervical cancer and childhood tumors; 2. Used for anti-tumor: leukemia, spermatogonial testicular cancer, lung cancer, non-Hodgkin's lymphoma, cervical cancer, ovarian cancer and recurrent and refractory solid tumors.
Manufacturer:
Jiangsu Hengrui Pharmaceuticals Co., Ltd.
Ifosfamide
Indication: 1. This product has a wide anti-tumor spectrum and is mainly suitable for soft tissue tumors, testicular tumors, malignant lymphomas, lung cancer, breast cancer, ovarian cancer, cervical cancer and childhood tumors; 2. Used for anti-tumor: leukemia, spermatogonial testicular cancer, lung cancer, non-Hodgkin's lymphoma, cervical cancer, ovarian cancer and recurrent and refractory solid tumors.
Ifosfamide
Indication: 1. This product has a wide anti-tumor spectrum and is mainly suitable for soft tissue tumors, testicular tumors, malignant lymphomas, lung cancer, breast cancer, ovarian cancer, cervical cancer and childhood tumors; 2. Used for anti-tumor: leukemia, spermatogonial testicular cancer, lung cancer, non-Hodgkin's lymphoma, cervical cancer, ovarian cancer and recurrent and refractory solid tumors.
Related Ingredients